Jiaxiao Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jiaxiao Shi has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Darios Getahun
Department of Research & Evaluation Kaiser Permanente Southern California Pasadena CA USA
14 shared publications - Vicki Y. Chiu
Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States
14 shared publications - Michael J. Fassett
Department of Obstetrics and Gynecology, Kaiser Permanente West Los Angeles Medical Center, Los Angeles, CA, United States
11 shared publications - Fagen Xie
Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States
10 shared publications - Chantal C. Avila
Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA
8 shared publications - Theresa M. Im
Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States
8 shared publications
Latest Publications
- Open Access
Perinatal outcomes after implementation of a blended virtual and in‐person prenatal care model in integrated healthcare systems
Background: Traditional US prenatal care typically includes 12–14 standardized in‐person visits. COVID‐19‐related barriers accelerated adoption of blended virtual/in‐person prenatal care, but evidence from large, diverse populations is limited. Objective: To compare perinatal outcomes after implementation of a blended prenatal care model versus traditional in‐person care in a large health maintenance organization. Methods: Retrospective cohort study in Kaiser Permanente Northwest and Southern California comparing blended care (cases, July 22, 2022 to December 31, 2024) with traditional in‐person care (controls, January 1, 2018 to December 31, 2019). Groups were compared using t ‐tests/Wilcoxon and chi‐square tests; multivariable logistic regression estimated adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Results: Among 47,577 patients (473 cases; 47,104 controls), cases were older at delivery (mean = 32.0 [SD = 4.6] vs. 30.4 [4.9] years, p < 0.0001), more likely to be non‐Hispanic White (68.9% vs. 26.5%, p < 0.0001), had higher median household income, and higher rates of publicly funded coverage (15.9% vs. 9.1%, p < 0.0001). Cases had fewer nulliparous women (20.9% vs. 47.5%, p < 0.0001), higher smoking rates (9.5% vs. 2.7%), and less likely to initiate prenatal care in the first trimester (92.6% vs. 96.8%). Cases had fewer in‐person visits (mean = 6.2 [2.7] vs. 15.7 [6.2], p < 0.0001), more virtual visits (3.2 [1.4] vs. 1.0 [1.4], p < 0.0001), and fewer total visits (9.4 [3.2] vs. 16.7 [6.5], p < 0.0001). Depression screening was more frequent in cases (84.1% vs. 45.9%, p < 0.0001). Compared to controls, cases had lower odds of preterm premature rupture of membranes (PPROM) (aOR, 0.17; 95% CI, 0.05–0.58), preterm birth <37 weeks (aOR, 0.37; 95% CI, 0.22–0.61), and stillbirth (aOR, 0.14; 95% CI, 0.03–0.70), but higher odds of non‐reassuring fetal heart rate tracing (aOR, 1.30; 95% CI, 1.06–1.60), gestational diabetes (aOR, 3.75; 95% CI, 2.80–5.01), and intrauterine growth restriction (IUGR; aOR, 2.46; 95% CI, 1.42–4.25). No significant differences were observed in placenta previa, chorioamnionitis, cesarean birth, postpartum hemorrhage, macrosomia, placental abruption, preeclampsia/eclampsia, or maternal length of stay more than 2 days. Conclusions: Blended virtual/in‐person prenatal care was associated with comparable perinatal outcomes despite fewer visits. Lower odds of preterm birth, PPROM, and stillbirth and higher odds of non‐reassuring fetal heart rate tracings, gestational diabetes, and IUGR suggest that blended care is feasible for low‐risk pregnancies, with attention to strengthening monitoring.
Open AccessPerinatal outcomes after implementation of a blended virtual and in‐person prenatal care model in integrated healthcare systems
Background: Traditional US prenatal care typically includes 12–14 standardized in‐person visits. COVID‐19‐related barriers accelerated adoption of blended virtual/in‐person prenatal care, but evidence from large, diverse populations is limited. Objective: To compare perinatal outcomes after implementation of a blended prenatal care model versus traditional in‐person care in a large health maintenance organization. Methods: Retrospective cohort study in Kaiser Permanente Northwest and Southern California comparing blended care (cases, July 22, 2022 to December 31, 2024) with traditional in‐person care (controls, January 1, 2018 to December 31, 2019). Groups were compared using t ‐tests/Wilcoxon and chi‐square tests; multivariable logistic regression estimated adjusted odds ratios (aORs) with 95% confidence intervals (CIs). Results: Among 47,577 patients (473 cases; 47,104 controls), cases were older at delivery (mean = 32.0 [SD = 4.6] vs. 30.4 [4.9] years, p < 0.0001), more likely to be non‐Hispanic White (68.9% vs. 26.5%, p < 0.0001), had higher median household income, and higher rates of publicly funded coverage (15.9% vs. 9.1%, p < 0.0001). Cases had fewer nulliparous women (20.9% vs. 47.5%, p < 0.0001), higher smoking rates (9.5% vs. 2.7%), and less likely to initiate prenatal care in the first trimester (92.6% vs. 96.8%). Cases had fewer in‐person visits (mean = 6.2 [2.7] vs. 15.7 [6.2], p < 0.0001), more virtual visits (3.2 [1.4] vs. 1.0 [1.4], p < 0.0001), and fewer total visits (9.4 [3.2] vs. 16.7 [6.5], p < 0.0001). Depression screening was more frequent in cases (84.1% vs. 45.9%, p < 0.0001). Compared to controls, cases had lower odds of preterm premature rupture of membranes (PPROM) (aOR, 0.17; 95% CI, 0.05–0.58), preterm birth <37 weeks (aOR, 0.37; 95% CI, 0.22–0.61), and stillbirth (aOR, 0.14; 95% CI, 0.03–0.70), but higher odds of non‐reassuring fetal heart rate tracing (aOR, 1.30; 95% CI, 1.06–1.60), gestational diabetes (aOR, 3.75; 95% CI, 2.80–5.01), and intrauterine growth restriction (IUGR; aOR, 2.46; 95% CI, 1.42–4.25). No significant differences were observed in placenta previa, chorioamnionitis, cesarean birth, postpartum hemorrhage, macrosomia, placental abruption, preeclampsia/eclampsia, or maternal length of stay more than 2 days. Conclusions: Blended virtual/in‐person prenatal care was associated with comparable perinatal outcomes despite fewer visits. Lower odds of preterm birth, PPROM, and stillbirth and higher odds of non‐reassuring fetal heart rate tracings, gestational diabetes, and IUGR suggest that blended care is feasible for low‐risk pregnancies, with attention to strengthening monitoring.
- Open Access
- 11 June 2026
- Published by Oxford University Press (OUP) in SLEEP Advances
- Vol. 7 (3) , zpag059
Large language model derived regular expressions for sleep phenotyping from electronic health record: a feasibility study
Study Objectives: Large language models may efficiently develop Regular Expression (regex)-based natural language processing for electronic health record phenotyping. We present PromptNLP to assess feasibility by evaluating performance and generalizability to clinical notes across multiple institutions. Methods: Sleep-related clinical notes from Kaiser Permanente Southern California, Beth Israel Deaconess Medical Center, and Emory University were used to extract apnea-hypopnea index and Epworth Sleepiness Scale. PromptNLP involves two steps: (1) build an apnea-hypopnea index/Epworth Sleepiness Scale phrase library (“Targeted” via manual, “General” via large language models); (2) input the library into an large language model with prompts to generate regex. For model development (Phase 1), we compared PromptNLP regexes with manual regex. For external validation (Phase 2), we adapted the Phase 1 Targeted regex to Beth Israel Deaconess Medical Center and Emory notes. For application (Phase 3), we applied adapted the regex to 207 404 Kaiser Permanente Southern California notes with validation against 8602 structured apnea-hypopnea index. Results: Phase 1: All Targeted PromptNLP regexes outperformed manual regex for recall (apnea-hypopnea index: 95%–96% vs 80.8%; Epworth Sleepiness Scale: 98%–100% vs 88%; p < .05). General regexes surpassed manual, but with lower recall. Phase 2: Direct Beth Israel Deaconess Medical Center application performed poorly (apnea-hypopnea index/Epworth Sleepiness Scale: 30%/12%), but adapting the phrase library improved recall to 96%/84%. For Emory, recall improved from 85%/86% to 94%/89% after adaptation. Across Phases 1 and 2, the PromptNLP regexes achieved 100% precision. Phase 3: 8216 (95.5%) apnea-hypopnea index values were correctly extracted with 99.8% precision. Conclusions: PromptNLP demonstrated feasibility as an efficient, accurate, and generalizable method, outperforming manual approaches and enabling iterative cross-system improvement. Systematic comparisons to direct large language model approaches are needed. Statement of Significance Transforming free-text clinical notes into reliable, structured data is essential for large-scale research and innovation in care delivery, yet existing approaches are limited by high manual effort, poor adaptability, or privacy concerns. This study introduces a novel framework, PromptNLP, that combines the strengths of generative artificial intelligence with rule-based extraction to enable accurate and scalable phenotyping from electronic health records. By improving the efficiency and generalizability of extracting key sleep-related measures across health systems, this work supports broader population studies and translational research in sleep medicine. Important next steps include clarifying when different text analysis approaches are most appropriate by comparing natural language processing methods and extending this framework to additional clinical domains.
- 11 June 2026
- Published by Oxford University Press (OUP) in SLEEP Advances
- Vol. 7 (3) , zpag059
Open AccessLarge language model derived regular expressions for sleep phenotyping from electronic health record: a feasibility study
Study Objectives: Large language models may efficiently develop Regular Expression (regex)-based natural language processing for electronic health record phenotyping. We present PromptNLP to assess feasibility by evaluating performance and generalizability to clinical notes across multiple institutions. Methods: Sleep-related clinical notes from Kaiser Permanente Southern California, Beth Israel Deaconess Medical Center, and Emory University were used to extract apnea-hypopnea index and Epworth Sleepiness Scale. PromptNLP involves two steps: (1) build an apnea-hypopnea index/Epworth Sleepiness Scale phrase library (“Targeted” via manual, “General” via large language models); (2) input the library into an large language model with prompts to generate regex. For model development (Phase 1), we compared PromptNLP regexes with manual regex. For external validation (Phase 2), we adapted the Phase 1 Targeted regex to Beth Israel Deaconess Medical Center and Emory notes. For application (Phase 3), we applied adapted the regex to 207 404 Kaiser Permanente Southern California notes with validation against 8602 structured apnea-hypopnea index. Results: Phase 1: All Targeted PromptNLP regexes outperformed manual regex for recall (apnea-hypopnea index: 95%–96% vs 80.8%; Epworth Sleepiness Scale: 98%–100% vs 88%; p < .05). General regexes surpassed manual, but with lower recall. Phase 2: Direct Beth Israel Deaconess Medical Center application performed poorly (apnea-hypopnea index/Epworth Sleepiness Scale: 30%/12%), but adapting the phrase library improved recall to 96%/84%. For Emory, recall improved from 85%/86% to 94%/89% after adaptation. Across Phases 1 and 2, the PromptNLP regexes achieved 100% precision. Phase 3: 8216 (95.5%) apnea-hypopnea index values were correctly extracted with 99.8% precision. Conclusions: PromptNLP demonstrated feasibility as an efficient, accurate, and generalizable method, outperforming manual approaches and enabling iterative cross-system improvement. Systematic comparisons to direct large language model approaches are needed. Statement of Significance Transforming free-text clinical notes into reliable, structured data is essential for large-scale research and innovation in care delivery, yet existing approaches are limited by high manual effort, poor adaptability, or privacy concerns. This study introduces a novel framework, PromptNLP, that combines the strengths of generative artificial intelligence with rule-based extraction to enable accurate and scalable phenotyping from electronic health records. By improving the efficiency and generalizability of extracting key sleep-related measures across health systems, this work supports broader population studies and translational research in sleep medicine. Important next steps include clarifying when different text analysis approaches are most appropriate by comparing natural language processing methods and extending this framework to additional clinical domains.
- Open Access
- 5 June 2026
- Published by JMIR Publications Inc. in JMIR Pediatrics and Parenting
- Vol. 9, e88772
Health Care Use and Recurrence Rate in Hemolytic Disease of the Fetus and Newborn: Retrospective Cohort Study
Background: Hemolytic disease of the fetus and newborn (HDFN) is a life-threatening condition resulting from maternal-fetal erythrocyte antigen incompatibility. Although anti–Rhesus D (RhD) prophylaxis has reduced RhD-associated cases, HDFN persists due to non-RhD antibodies and gaps in prevention. Population-based data on maternal and neonatal outcomes and recurrence patterns are limited. Objective: This study aimed to characterize maternal and neonatal outcomes, health care use patterns, and recurrence rates of HDFN across pregnancies. Methods: We conducted a retrospective cohort study of 464,711 pregnancies within the Kaiser Permanente Southern California system from January 1, 2008, to June 30, 2022. HDFN diagnoses were confirmed using validated natural language processing–assisted manual chart review and followed through 2023. Maternal characteristics, neonatal outcomes, and health care use were compared by HDFN status, and recurrence patterns were evaluated among individuals with ≥2 pregnancies. Chi-square tests and Wilcoxon rank-sum tests were used to compare characteristics between HDFN and non-HDFN pregnancies. Statistical significance was defined as P<.05. Results: Among all pregnancies, 139 of 464,711 (0.03%) were diagnosed with HDFN. Women with HDFN were more likely than those without HDFN to be older (aged ≥35 years; n=42, 30.2% vs n=97,146, 20.9%) and multiparous (n=121, 87.1% vs n=264,766, 57%). Infants affected by HDFN had higher rates of preterm birth (n=40, 28.4% vs n=42,240, 9.5%), low birth weight (<2500 g; n=22, 15.6% vs n=31,740, 7.1%), and neonatal jaundice (n=92, 65.2% vs n=162,465, 36.4%) than non-HDFN infants. Delivery hospitalizations (median 5.0, IQR 2.0-7.5 days vs median 2.0, IQR 1.0-2.0 days) and neonatal intensive care unit stays (median 4.0, IQR 0.0-7.0 days vs median 0.0, IQR 0.0-0.0 days) were longer, and maternal nondelivery hospitalizations were more frequent (n=27, 19.4% vs n=23,228, 5%) among pregnancies complicated by HDFN. Among women with a prior HDFN-affected pregnancy, 83.3% (n=25) experienced recurrence in a subsequent pregnancy. Of these recurrent cases, 32% (n=8) were severe, and 75% (n=6) involved fetal anemia requiring at least 1 intrauterine transfusion. Conclusions: HDFN was rare but was associated with substantial maternal and neonatal morbidity, including higher rates of preterm birth, increased neonatal intensive care unit admissions, and greater health care use. Recurrence was frequent and clinically significant, underscoring the importance of early surveillance and proactive management strategies.
- 5 June 2026
- Published by JMIR Publications Inc. in JMIR Pediatrics and Parenting
- Vol. 9, e88772
Open AccessHealth Care Use and Recurrence Rate in Hemolytic Disease of the Fetus and Newborn: Retrospective Cohort Study
Background: Hemolytic disease of the fetus and newborn (HDFN) is a life-threatening condition resulting from maternal-fetal erythrocyte antigen incompatibility. Although anti–Rhesus D (RhD) prophylaxis has reduced RhD-associated cases, HDFN persists due to non-RhD antibodies and gaps in prevention. Population-based data on maternal and neonatal outcomes and recurrence patterns are limited. Objective: This study aimed to characterize maternal and neonatal outcomes, health care use patterns, and recurrence rates of HDFN across pregnancies. Methods: We conducted a retrospective cohort study of 464,711 pregnancies within the Kaiser Permanente Southern California system from January 1, 2008, to June 30, 2022. HDFN diagnoses were confirmed using validated natural language processing–assisted manual chart review and followed through 2023. Maternal characteristics, neonatal outcomes, and health care use were compared by HDFN status, and recurrence patterns were evaluated among individuals with ≥2 pregnancies. Chi-square tests and Wilcoxon rank-sum tests were used to compare characteristics between HDFN and non-HDFN pregnancies. Statistical significance was defined as P<.05. Results: Among all pregnancies, 139 of 464,711 (0.03%) were diagnosed with HDFN. Women with HDFN were more likely than those without HDFN to be older (aged ≥35 years; n=42, 30.2% vs n=97,146, 20.9%) and multiparous (n=121, 87.1% vs n=264,766, 57%). Infants affected by HDFN had higher rates of preterm birth (n=40, 28.4% vs n=42,240, 9.5%), low birth weight (<2500 g; n=22, 15.6% vs n=31,740, 7.1%), and neonatal jaundice (n=92, 65.2% vs n=162,465, 36.4%) than non-HDFN infants. Delivery hospitalizations (median 5.0, IQR 2.0-7.5 days vs median 2.0, IQR 1.0-2.0 days) and neonatal intensive care unit stays (median 4.0, IQR 0.0-7.0 days vs median 0.0, IQR 0.0-0.0 days) were longer, and maternal nondelivery hospitalizations were more frequent (n=27, 19.4% vs n=23,228, 5%) among pregnancies complicated by HDFN. Among women with a prior HDFN-affected pregnancy, 83.3% (n=25) experienced recurrence in a subsequent pregnancy. Of these recurrent cases, 32% (n=8) were severe, and 75% (n=6) involved fetal anemia requiring at least 1 intrauterine transfusion. Conclusions: HDFN was rare but was associated with substantial maternal and neonatal morbidity, including higher rates of preterm birth, increased neonatal intensive care unit admissions, and greater health care use. Recurrence was frequent and clinically significant, underscoring the importance of early surveillance and proactive management strategies.
- Open Access
Preconception metabolic-bariatric surgery and child health outcomes: Identification and cohort profile of the POSIT study protocol
Preconception weight loss by metabolic-bariatric surgery (MBS) improves maternal-fetal outcomes, but little is known about its impact on offspring growth and health. The preconception bariatric surgery and child health outcomes (POSIT) study aims to estimate the effects of maternal MBS-induced preconception weight loss on infant and childhood body size, growth, and related outcomes. This report presents the methods used to construct the POSIT cohort and its baseline characteristics. This retrospective cohort study sampled members from a United States healthcare system aged 18 and older with a singleton, live birth to create three study groups: 1) a treatment group including women who underwent preconception MBS and subsequently became pregnant (n=1,374); 2) a control group matched to the MBS pre-surgery body mass index (BMI) (pre-surgery controls, n=13,740); and 3) a second control group matched to the MBS post-surgical, pre-pregnancy BMI (pre-pregnancy controls, n=13,740). MBS and pre-surgery BMI controls showed slight imbalances in that pre-surgery BMI controls were on average ∼6 months younger, had 0.6 lower BMI (44.5 kg/m 2 ) at the time of their pregnancy and were more likely to have become pregnant in earlier years than the MBS group prior to surgery. MBS and pre-pregnancy controls had comparable age (mean ± SD 33 ± 5 years), pre-pregnancy BMI (33 ± 6 kg/m 2 ), and year of delivery. Following matching, the MBS group had similar socioeconomic and health disparities as the pre-surgery control group, and both were worse than pre-pregnancy control group. Pregestational maternal comorbidity index improved after MBS and matched the pre-pregnancy controls. Upon extraction of offspring growth patterns and mediation analyses of maternal weight loss and metabolic responses to MBS, study findings will investigate effects of preconception weight loss by MBS on short- and long-term child health outcomes. Results will guide future studies focusing on improving maternal preconception weight and maternal-fetal outcomes.
Open AccessPreconception metabolic-bariatric surgery and child health outcomes: Identification and cohort profile of the POSIT study protocol
Preconception weight loss by metabolic-bariatric surgery (MBS) improves maternal-fetal outcomes, but little is known about its impact on offspring growth and health. The preconception bariatric surgery and child health outcomes (POSIT) study aims to estimate the effects of maternal MBS-induced preconception weight loss on infant and childhood body size, growth, and related outcomes. This report presents the methods used to construct the POSIT cohort and its baseline characteristics. This retrospective cohort study sampled members from a United States healthcare system aged 18 and older with a singleton, live birth to create three study groups: 1) a treatment group including women who underwent preconception MBS and subsequently became pregnant (n=1,374); 2) a control group matched to the MBS pre-surgery body mass index (BMI) (pre-surgery controls, n=13,740); and 3) a second control group matched to the MBS post-surgical, pre-pregnancy BMI (pre-pregnancy controls, n=13,740). MBS and pre-surgery BMI controls showed slight imbalances in that pre-surgery BMI controls were on average ∼6 months younger, had 0.6 lower BMI (44.5 kg/m 2 ) at the time of their pregnancy and were more likely to have become pregnant in earlier years than the MBS group prior to surgery. MBS and pre-pregnancy controls had comparable age (mean ± SD 33 ± 5 years), pre-pregnancy BMI (33 ± 6 kg/m 2 ), and year of delivery. Following matching, the MBS group had similar socioeconomic and health disparities as the pre-surgery control group, and both were worse than pre-pregnancy control group. Pregestational maternal comorbidity index improved after MBS and matched the pre-pregnancy controls. Upon extraction of offspring growth patterns and mediation analyses of maternal weight loss and metabolic responses to MBS, study findings will investigate effects of preconception weight loss by MBS on short- and long-term child health outcomes. Results will guide future studies focusing on improving maternal preconception weight and maternal-fetal outcomes.
- 24 April 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (2) , 137
Obstructive sleep apnea, positive airway pressure therapy, and COVID-19 outcomes
- 24 April 2026
- Published by Springer Nature in Sleep and Breathing
- Vol. 30 (2) , 137
Obstructive sleep apnea, positive airway pressure therapy, and COVID-19 outcomes
- 9 April 2026
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (10) , 2636-2639
Medicare Coverage Requirements and Real-world CPAP Utilization: Early Non-adherence Does not Exclude Long-term Use
- 9 April 2026
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 212 (10) , 2636-2639
Medicare Coverage Requirements and Real-world CPAP Utilization: Early Non-adherence Does not Exclude Long-term Use
- Open Access
- 9 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e77836
Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies
Background: Hemolytic disease of the fetus and newborn (HDFN) is a rare but serious condition caused by maternal-fetal red blood cell antigen incompatibility. In an affected pregnancy, maternal immunoglobulin G antibodies cross the placenta and target fetal or neonatal red blood cells, leading to hemolysis, hyperbilirubinemia, and anemia. Although routine screening and alloimmunization prevention programs have contributed to the decline in HDFN in the United States, further understanding of its epidemiology is still needed. Objective: This protocol aims to provide an overview of the study design, methodology, and analytical approach used to investigate the epidemiology, treatment, and health care resource use of HDFN within a large integrated health care system. Methods: We conducted a retrospective cohort study of pregnant women who received obstetric care in the Kaiser Permanente Southern California (KPSC) health care system from January 1, 2008, to June 30, 2022. To identify HDFN cases, we used a novel methodology developed by KPSC researchers combining structured data and detailed clinical information extracted from unstructured records via a natural language processing–assisted chart review process. Chi-square and Wilcoxon rank sum tests were used to compare the distributions of maternal and infant demographic characteristics, as well as medical and perinatal conditions, by HDFN status. We also evaluated the association between HDFN and adverse perinatal outcomes using logistic regression models. Planned analyses using this unique cohort will include describing the annual prevalence, health care resource use, and treatment patterns of mothers and infants by HDFN status. Results: The study population consisted of 464,711 pregnancies, of which 136 (0.03%) were HDFN cases confirmed by chart review, resulting in 138 (0.03%) births (n=137, 0.99% live births and n=1, 0.01% stillbirth). The mean age at pregnancy was 29.8 (SD 5.7) years, and the population was racially and ethnically diverse. Conclusions: We present an overview of the methodology developed by KPSC clinicians and researchers on the epidemiology, treatment, and health care resource use of HDFN within a large and demographically diverse population of pregnant women. Our novel methodology, combining both structured and unstructured data and a natural language processing–assisted chart review process, ensures the successful identification of true cases to carry out pharmaco-epidemiological studies. International Registered Report Identifier (IRRID): DERR1-10.2196/77836
- 9 December 2025
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 14, e77836
Open AccessFeasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies
Background: Hemolytic disease of the fetus and newborn (HDFN) is a rare but serious condition caused by maternal-fetal red blood cell antigen incompatibility. In an affected pregnancy, maternal immunoglobulin G antibodies cross the placenta and target fetal or neonatal red blood cells, leading to hemolysis, hyperbilirubinemia, and anemia. Although routine screening and alloimmunization prevention programs have contributed to the decline in HDFN in the United States, further understanding of its epidemiology is still needed. Objective: This protocol aims to provide an overview of the study design, methodology, and analytical approach used to investigate the epidemiology, treatment, and health care resource use of HDFN within a large integrated health care system. Methods: We conducted a retrospective cohort study of pregnant women who received obstetric care in the Kaiser Permanente Southern California (KPSC) health care system from January 1, 2008, to June 30, 2022. To identify HDFN cases, we used a novel methodology developed by KPSC researchers combining structured data and detailed clinical information extracted from unstructured records via a natural language processing–assisted chart review process. Chi-square and Wilcoxon rank sum tests were used to compare the distributions of maternal and infant demographic characteristics, as well as medical and perinatal conditions, by HDFN status. We also evaluated the association between HDFN and adverse perinatal outcomes using logistic regression models. Planned analyses using this unique cohort will include describing the annual prevalence, health care resource use, and treatment patterns of mothers and infants by HDFN status. Results: The study population consisted of 464,711 pregnancies, of which 136 (0.03%) were HDFN cases confirmed by chart review, resulting in 138 (0.03%) births (n=137, 0.99% live births and n=1, 0.01% stillbirth). The mean age at pregnancy was 29.8 (SD 5.7) years, and the population was racially and ethnically diverse. Conclusions: We present an overview of the methodology developed by KPSC clinicians and researchers on the epidemiology, treatment, and health care resource use of HDFN within a large and demographically diverse population of pregnant women. Our novel methodology, combining both structured and unstructured data and a natural language processing–assisted chart review process, ensures the successful identification of true cases to carry out pharmaco-epidemiological studies. International Registered Report Identifier (IRRID): DERR1-10.2196/77836
- Open Access
- 2 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Health Care Use and Recurrence Rate in Hemolytic Disease of the Fetus and Newborn: Retrospective Cohort Study (Preprint)
BACKGROUND Hemolytic disease of the fetus and newborn (HDFN) is a life-threatening condition resulting from maternal-fetal erythrocyte antigen incompatibility. Although anti–Rhesus D (RhD) prophylaxis has reduced RhD-associated cases, HDFN persists due to non-RhD antibodies and gaps in prevention. Population-based data on maternal and neonatal outcomes and recurrence patterns are limited. OBJECTIVE This study aimed to characterize maternal and neonatal outcomes, health care use patterns, and recurrence rates of HDFN across pregnancies. METHODS We conducted a retrospective cohort study of 464,711 pregnancies within the Kaiser Permanente Southern California system from January 1, 2008, to June 30, 2022. HDFN diagnoses were confirmed using validated natural language processing–assisted manual chart review and followed through 2023. Maternal characteristics, neonatal outcomes, and health care use were compared by HDFN status, and recurrence patterns were evaluated among individuals with ≥2 pregnancies. Chi-square tests and Wilcoxon rank-sum tests were used to compare characteristics between HDFN and non-HDFN pregnancies. Statistical significance was defined as P<.05. RESULTS Among all pregnancies, 139 of 464,711 (0.03%) were diagnosed with HDFN. Women with HDFN were more likely than those without HDFN to be older (aged ≥35 years; n=42, 30.2% vs n=97,146, 20.9%) and multiparous (n=121, 87.1% vs n=264,766, 57%). Infants affected by HDFN had higher rates of preterm birth (n=40, 28.4% vs n=42,240, 9.5%), low birth weight (<2500 g; n=22, 15.6% vs n=31,740, 7.1%), and neonatal jaundice (n=92, 65.2% vs n=162,465, 36.4%) than non-HDFN infants. Delivery hospitalizations (median 5.0, IQR 2.0-7.5 days vs median 2.0, IQR 1.0-2.0 days) and neonatal intensive care unit stays (median 4.0, IQR 0.0-7.0 days vs median 0.0, IQR 0.0-0.0 days) were longer, and maternal nondelivery hospitalizations were more frequent (n=27, 19.4% vs n=23,228, 5%) among pregnancies complicated by HDFN. Among women with a prior HDFN-affected pregnancy, 83.3% (n=25) experienced recurrence in a subsequent pregnancy. Of these recurrent cases, 32% (n=8) were severe, and 75% (n=6) involved fetal anemia requiring at least 1 intrauterine transfusion. CONCLUSIONS HDFN was rare but was associated with substantial maternal and neonatal morbidity, including higher rates of preterm birth, increased neonatal intensive care unit admissions, and greater health care use. Recurrence was frequent and clinically significant, underscoring the importance of early surveillance and proactive management strategies.
- 2 December 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessHealth Care Use and Recurrence Rate in Hemolytic Disease of the Fetus and Newborn: Retrospective Cohort Study (Preprint)
BACKGROUND Hemolytic disease of the fetus and newborn (HDFN) is a life-threatening condition resulting from maternal-fetal erythrocyte antigen incompatibility. Although anti–Rhesus D (RhD) prophylaxis has reduced RhD-associated cases, HDFN persists due to non-RhD antibodies and gaps in prevention. Population-based data on maternal and neonatal outcomes and recurrence patterns are limited. OBJECTIVE This study aimed to characterize maternal and neonatal outcomes, health care use patterns, and recurrence rates of HDFN across pregnancies. METHODS We conducted a retrospective cohort study of 464,711 pregnancies within the Kaiser Permanente Southern California system from January 1, 2008, to June 30, 2022. HDFN diagnoses were confirmed using validated natural language processing–assisted manual chart review and followed through 2023. Maternal characteristics, neonatal outcomes, and health care use were compared by HDFN status, and recurrence patterns were evaluated among individuals with ≥2 pregnancies. Chi-square tests and Wilcoxon rank-sum tests were used to compare characteristics between HDFN and non-HDFN pregnancies. Statistical significance was defined as P<.05. RESULTS Among all pregnancies, 139 of 464,711 (0.03%) were diagnosed with HDFN. Women with HDFN were more likely than those without HDFN to be older (aged ≥35 years; n=42, 30.2% vs n=97,146, 20.9%) and multiparous (n=121, 87.1% vs n=264,766, 57%). Infants affected by HDFN had higher rates of preterm birth (n=40, 28.4% vs n=42,240, 9.5%), low birth weight (<2500 g; n=22, 15.6% vs n=31,740, 7.1%), and neonatal jaundice (n=92, 65.2% vs n=162,465, 36.4%) than non-HDFN infants. Delivery hospitalizations (median 5.0, IQR 2.0-7.5 days vs median 2.0, IQR 1.0-2.0 days) and neonatal intensive care unit stays (median 4.0, IQR 0.0-7.0 days vs median 0.0, IQR 0.0-0.0 days) were longer, and maternal nondelivery hospitalizations were more frequent (n=27, 19.4% vs n=23,228, 5%) among pregnancies complicated by HDFN. Among women with a prior HDFN-affected pregnancy, 83.3% (n=25) experienced recurrence in a subsequent pregnancy. Of these recurrent cases, 32% (n=8) were severe, and 75% (n=6) involved fetal anemia requiring at least 1 intrauterine transfusion. CONCLUSIONS HDFN was rare but was associated with substantial maternal and neonatal morbidity, including higher rates of preterm birth, increased neonatal intensive care unit admissions, and greater health care use. Recurrence was frequent and clinically significant, underscoring the importance of early surveillance and proactive management strategies.
- Open Access
- 21 May 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies (Preprint)
BACKGROUND Hemolytic disease of the fetus and newborn (HDFN) is a rare but serious condition caused by maternal-fetal red blood cell antigen incompatibility. In an affected pregnancy, maternal immunoglobulin G antibodies cross the placenta and target fetal or neonatal red blood cells, leading to hemolysis, hyperbilirubinemia, and anemia. Although routine screening and alloimmunization prevention programs have contributed to the decline in HDFN in the United States, further understanding of its epidemiology is still needed. OBJECTIVE This protocol aims to provide an overview of the study design, methodology, and analytical approach used to investigate the epidemiology, treatment, and health care resource use of HDFN within a large integrated health care system. METHODS We conducted a retrospective cohort study of pregnant women who received obstetric care in the Kaiser Permanente Southern California (KPSC) health care system from January 1, 2008, to June 30, 2022. To identify HDFN cases, we used a novel methodology developed by KPSC researchers combining structured data and detailed clinical information extracted from unstructured records via a natural language processing–assisted chart review process. Chi-square and Wilcoxon rank sum tests were used to compare the distributions of maternal and infant demographic characteristics, as well as medical and perinatal conditions, by HDFN status. We also evaluated the association between HDFN and adverse perinatal outcomes using logistic regression models. Planned analyses using this unique cohort will include describing the annual prevalence, health care resource use, and treatment patterns of mothers and infants by HDFN status. RESULTS The study population consisted of 464,711 pregnancies, of which 136 (0.03%) were HDFN cases confirmed by chart review, resulting in 138 (0.03%) births (n=137, 0.99% live births and n=1, 0.01% stillbirth). The mean age at pregnancy was 29.8 (SD 5.7) years, and the population was racially and ethnically diverse. CONCLUSIONS We present an overview of the methodology developed by KPSC clinicians and researchers on the epidemiology, treatment, and health care resource use of HDFN within a large and demographically diverse population of pregnant women. Our novel methodology, combining both structured and unstructured data and a natural language processing–assisted chart review process, ensures the successful identification of true cases to carry out pharmaco-epidemiological studies. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/77836
- 21 May 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFeasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies (Preprint)
BACKGROUND Hemolytic disease of the fetus and newborn (HDFN) is a rare but serious condition caused by maternal-fetal red blood cell antigen incompatibility. In an affected pregnancy, maternal immunoglobulin G antibodies cross the placenta and target fetal or neonatal red blood cells, leading to hemolysis, hyperbilirubinemia, and anemia. Although routine screening and alloimmunization prevention programs have contributed to the decline in HDFN in the United States, further understanding of its epidemiology is still needed. OBJECTIVE This protocol aims to provide an overview of the study design, methodology, and analytical approach used to investigate the epidemiology, treatment, and health care resource use of HDFN within a large integrated health care system. METHODS We conducted a retrospective cohort study of pregnant women who received obstetric care in the Kaiser Permanente Southern California (KPSC) health care system from January 1, 2008, to June 30, 2022. To identify HDFN cases, we used a novel methodology developed by KPSC researchers combining structured data and detailed clinical information extracted from unstructured records via a natural language processing–assisted chart review process. Chi-square and Wilcoxon rank sum tests were used to compare the distributions of maternal and infant demographic characteristics, as well as medical and perinatal conditions, by HDFN status. We also evaluated the association between HDFN and adverse perinatal outcomes using logistic regression models. Planned analyses using this unique cohort will include describing the annual prevalence, health care resource use, and treatment patterns of mothers and infants by HDFN status. RESULTS The study population consisted of 464,711 pregnancies, of which 136 (0.03%) were HDFN cases confirmed by chart review, resulting in 138 (0.03%) births (n=137, 0.99% live births and n=1, 0.01% stillbirth). The mean age at pregnancy was 29.8 (SD 5.7) years, and the population was racially and ethnically diverse. CONCLUSIONS We present an overview of the methodology developed by KPSC clinicians and researchers on the epidemiology, treatment, and health care resource use of HDFN within a large and demographically diverse population of pregnant women. Our novel methodology, combining both structured and unstructured data and a natural language processing–assisted chart review process, ensures the successful identification of true cases to carry out pharmaco-epidemiological studies. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/77836